Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

REGENERON PHARMACEUTICALS, INC

Filed by REGENERON PHARMACEUTICALS, INC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
Not reported
Expenses
$570,000.00
Filing UUID
63f47ddf-43b4-4741-a92a-5edc748abbe6
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Trade and tariff issues related to corporations.

TAX · Taxation/Internal Revenue Code

Tax and inflation issues related to corporations.

HCR · Health Issues

Privacy legislation related to biopharmaceutical manufacturers; Food and Drug Administration issues related to biopharmaceutical manufacturers; National security issues related to biopharmaceutical manufacturers; Public-private contracts for innovation in the biopharmaceutical space; Issues related to defense spending; Issues related to step therapy; Issues related to health extenders; Issues related to Pandemic Preparedness and Response Program.

MMM · Medicare/Medicaid

Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers.

CPT · Copyright/Patent/Trademark

Patent issues relating to biopharmaceutical manufacturers; Intellectual property legislation related to biopharmaceutical manufacturers; Issues relating to WTO TRIPS waivers.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.